New drug trial aims to slow knee arthritis damage
NCT ID NCT07323745
Summary
This early-stage study will test whether taking the drug Mobithron Advance daily for one year can slow the progression of knee osteoarthritis and help preserve cartilage. Researchers will follow 84 adults over 50 with mild to moderate knee arthritis, using MRI scans to measure cartilage thickness and questionnaires to track pain and function. The main goal is to see if the drug is safe for long-term use and if it can modify the disease course compared to a placebo.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS (OA) OF THE KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital Univerisiti Sains Malaysia (HUSM)
Kota Bharu, Kelantan, 16150, Malaysia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.